Harvard 4th Annual Update in Neuro-Oncology 2024

Overview

Harvard 4th Annual Update in Neuro-Oncology 2024 is a comprehensive three-day CME-aligned learning course designed to provide an international audience with the latest advances in the diagnosis and management of pediatric and adult patients with primary and metastatic tumors of the central and peripheral nervous systems, as well as neurological complications of cancer. This course integrates perspectives from medical, radiation, and surgical neuro-oncology, enhanced by modern molecular neuropathology and neuroradiology insights.

On-demand neuro-oncology education — accessible anytime, anywhere.

Agenda

This agenda presents a detailed schedule of sessions, organized over three days in Eastern Daylight Time (EDT), covering key topics in pediatric neuro-oncology, adult neuro-oncology, and neurological complications of cancer. Each day includes expert presentations and live Q&A sessions that offer opportunities to deepen understanding and clinical expertise.

• Welcome: Pediatric Neuro-Oncology Session — Scott Pomeroy, MD, PhD
• Keynote: Targeted Therapy for Pediatric Low-Grade Glioma — Karen Wright, MD
• WHO Classification, Pediatric CNS Tumors — Sanda Alexandrescu, MD
• Advances in the Imaging of Pediatric Brain Tumors — Tina Young Poussaint, MD, FACR
• Embryonal Tumors — Scott Pomeroy, MD, PhD
• Break
• Pediatric Low-Grade Gliomas — Susan Chi, MD
• Pediatric High-Grade Gliomas — Mariella Filbin, MD, PhD
• Ependymomas — Pratiti Bandopadhayay, MBBS, PhD
• Live Q&A Session — Scott Pomeroy, MD, PhD
• Break
• Choroid Plexus Tumors — Viviana Benitez, MD
• Pineal Tumors — Shannon MacDonald, MD
• Germ Cell Tumors — Kee Kiat Yeo, MD
• Neurofibromatosis — Scott Plotkin, MD, PhD
• Von Hippel Lindau — Othon Iliopoulos, MD
• Live Q&A Session — Scott Pomeroy, MD, PhD
• Welcome: Adult Neuro-Oncology — Bob Carter, MD, PhD
• Keynote: CAR-T Cell Therapy for Glioblastoma — Bryan Choi, MD, PhD
• Advances in Surgery for Brain Tumors — E. Antonio Chiocca, MD, PhD
• Advances in Imaging for Brain Tumors — Pamela Schaefer, MD, FACR
• Advances in Radiation for Brain Tumors — Helen Shih, MD
• Live Question and Answer Session — Bob Carter, MD, PhD
• Break
• WHO Classification for Adult Gliomas — Maria Martinez—Lage Alvarez, MD
• Gliomas, IDH-Mutant — Nicolas Gonzalez Castro, MD, PhD
• Gliomas, IDH-Wildtype — Isabel Arrillaga-Romany, MD, PhD
• Advances in Experimental Therapies for Gliomas — David Reardon, MD
• Break
• Meningioma — Wenya Linda Bi, MD, PhD
• CNS Lymphomas — Tracy Batchelor, MD, MPH
• Pituitary Tumors — Pamela Jones, MD
• Live Question & Answer Session — Bob Carter, MD, PhD
• Adjourn — Bob Carter, MD, PhD
• Welcome: Neurological Complications of Cancer — Patrick Wen, MD
• Keynote: The Oncogenic Origins of Temporal Lobe Epilepsy — Sattar Khoshkhoo, MD
• Metastases to the Brain — Priscilla Brastianos, MD
• Metastases to the Leptomeninges — Jose Ricardo McFaline-Figueroa, MD, PhD
• Metastases to the Epidural Space and Spinal Cord — John Chi, MD, MPH
• Live Question and Answer Session — Patrick Wen, MD
• Break
• Paraneoplastic Neurological Syndromes — Eudocia Lee, MD, MPH
• Common Neurological Complications in Cancer Patients — Nancy Wang, MD
• Neurological Complications of Cancer Immunotherapies — Jorg Dietrich, MD, PhD
• Managing Long-Term Survivors of CNS Tumors — Deborah Forst, MD
• The Role of the Neuropsychologist in Neuro-Oncology — Michael Parsons, PhD, ABPP
• Live Question and Answer Session — Patrick Wen, MD
• Closing Statements — Tracy Batchelor, MD, MPH

Learning Objectives

Upon completion of this activity, participants will be able to:

• Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
• Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
• Recognize and manage neurological complications associated with new cancer therapies.
• Identify and manage long-term complications of CNS and PNS tumors and their treatment.

Speakers

• Scott Pomeroy, MD, PhD
• Karen Wright, MD
• Sanda Alexandrescu, MD
• Tina Young Poussaint, MD, FACR
• Susan Chi, MD
• Mariella Filbin, MD, PhD
• Pratiti Bandopadhayay, MBBS, PhD
• Viviana Benitez, MD
• Shannon MacDonald, MD
• Kee Kiat Yeo, MD
• Scott Plotkin, MD, PhD
• Othon Iliopoulos, MD
• Bob Carter, MD, PhD
• Bryan Choi, MD, PhD
• E. Antonio Chiocca, MD, PhD
• Pamela Schaefer, MD, FACR
• Helen Shih, MD
• Maria Martinez—Lage Alvarez, MD
• Nicolas Gonzalez Castro, MD, PhD
• Isabel Arrillaga-Romany, MD, PhD
• David Reardon, MD
• Wenya Linda Bi, MD, PhD
• Tracy Batchelor, MD, MPH
• Pamela Jones, MD
• Patrick Wen, MD
• Sattar Khoshkhoo, MD
• Priscilla Brastianos, MD
• Jose Ricardo McFaline-Figueroa, MD, PhD
• John Chi, MD, MPH
• Eudocia Lee, MD, MPH
• Nancy Wang, MD
• Jorg Dietrich, MD, PhD
• Deborah Forst, MD
• Michael Parsons, PhD, ABPP

Target Audience

This course is intended for healthcare professionals involved in neuro-oncology care including oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, neuropathologists, nurse practitioners, physician assistants, psychologists, pharmacists, and nurses seeking to strengthen their expertise in managing patients with CNS and PNS tumors and related neurological complications.

Why This Topic Matters

Harvard 4th Annual Update in Neuro-Oncology 2024 reflects the dynamic advancements in neuro-oncology within neurology and oncology specialties. Given the complexity of CNS and PNS tumors, incorporating multidisciplinary knowledge including molecular diagnostics and treatment innovations is essential for effective patient management.

MedHub Central provides access to this vital educational resource, supporting professionals who require up-to-date clinical insights to enhance confidence and knowledge in neuro-oncology practice.